Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04888312
Title Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients (OPTIMIZE-1)
Acronym OPTIMIZE-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Alligator Bioscience AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP | BEL

Facility Status City State Zip Country Details
Cliniques Universitaires St-Luc RECRUITING Brussels Belgium Details
Hospital Erasme RECRUITING Bruxelles Belgium Details
Grand Hôpital de Charleroi WITHDRAWN Charleroi Belgium Details
UZA Antwerp RECRUITING Edegem Belgium Details
Universitair Ziekenhuis Gent RECRUITING Gent 9000 Belgium Details
Centre Hospitalier Universitaire de Bordeaux - Hôpital Haut-Lévêque, RECRUITING Bordeaux France Details
Centre Lyon Berard RECRUITING Lyon France Details
Institut Paoli-Calmettes RECRUITING Marseille France Details
Hopital Européen Georges Pompidou ACTIVE_NOT_RECRUITING Paris 75015 France Details
Institute de Cancérologie de l'Ouest WITHDRAWN Saint-Herblain France Details
Institute de Cancérologie de Lorraine RECRUITING Vandœuvre-lès-Nancy France Details
Hospital Universitario Vall d'Hebron, Barcelona, Spain RECRUITING Barcelona Spain Details
Hospital Universitario La Paz, Madrid, Spain RECRUITING Madrid Spain Details
Hospital Universitario Ramon y Cajal, Madrid, Spain RECRUITING Madrid Spain Details
Hospital Universitario Virgen del Rocio, Sevilla, Spain RECRUITING Sevilla Spain Details
Hospital Universitario Miguel Servet, Zaragoza, Spain RECRUITING Zaragoza Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field